Responses
Clinical and epidemiological research
Extended report
Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction
Compose a Response to This Article
Other responses
No responses have been published for this article.